Distinct Immune-microenvironment Construction Diversely Responded to Induction Immunotherapy among Multiple Primary Lung Adenocarcinoma
Ontology highlight
ABSTRACT: We performed an integrated multi-omics analysis including single-cell RNA sequencing in one multiple lung nodules patient treated with pembrolizumab. We found that responded nodule showed notably higher infiltrating macrophages and lymphocytes through mIHC. Much higher genomic somatic copy number variants events were observed in two non-responded nodules. scRNA highlighted HLA-related gene down-regulation in both non-responded nodules indicating one of its immune evasion mechanisms. Moreover, significantly high proportion of Tissue resident memory T cells were found in responded nodule which has been validated to be both predictive and prognostic signature among multiple cancer types through external datasets. As for macrophages, MDSC-like subtype was predominantly observed in responded nodule while TAM-like subtype mainly in other two non-responded nodules. Through TCGA-LUAD cohort, MDSC-like macrophages showed inferior prognostic value compared to TAM-like macrophages suggesting a potential resistant mechanism along with increased responded immune infiltration. This study provides an in-depth multi-omics analysis on firstly reported multiple primary lung adenocarcinoma receiving immunotherapy and describes potential early immune signals responding to immunotherapy, as well as impaired antigen-presenting process in sub-solid nodules which may attribute to primary resistant of immunotherapy.
ORGANISM(S): Homo sapiens
PROVIDER: GSE146100 | GEO | 2021/04/28
REPOSITORIES: GEO
ACCESS DATA